Long-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant

Sponsor
Oticon Medical (Industry)
Overall Status
Completed
CT.gov ID
NCT01738490
Collaborator
(none)
59
1
2
54
1.1

Study Details

Study Description

Brief Summary

The overall aim of the study is to investigate the Ponto wide implant considering; initial implant stability, stability over time, skin reaction and long term success when loaded at 3 weeks post surgery. Patients' quality of life improvements following implantation will also be surveyed.

More specifically the primary objective of this clinical study is to test the hypothesis

  • The new Ponto wide diameter implant offers increased implant stability measured as ISQ (implant stability quotient) compared to the previous generation Ponto implant.

And the secondary objective is to

  • Investigate when in time implant stability is the lowest as the initial mechanical stability is gradually replaced by biological stability
Condition or Disease Intervention/Treatment Phase
  • Device: Bone anchored hearing implant
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Long-term Stability and Survival Rates of a Novel Oticon Medical Bone Conduction Device Implant
Study Start Date :
Jun 1, 2012
Actual Primary Completion Date :
Jun 1, 2014
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Other: Wide diameter implant

Bone anchored hearing implant For the wide diameter arm (test group), the Ponto wide implant (diameter 4,5mm, length 4mm) and abutment 6mm developed by Oticon Medical AB (Gothenburg, Sweden) will be installed.

Device: Bone anchored hearing implant
Other Names:
  • Ponto implant
  • Bone anchored hearing aid
  • Other: Control group

    Bone anchored hearing implant For the control group, the previous generation Ponto implant (diameter 3,75mm, length 4mm) and 6mm abutment (Oticon Medical AB, Gothenburg, Sweden) will be installed.

    Device: Bone anchored hearing implant
    Other Names:
  • Ponto implant
  • Bone anchored hearing aid
  • Outcome Measures

    Primary Outcome Measures

    1. ISQ (Implant Stability Quotient) [Surgery (0 days)]

      ISQ (implant Stability Quotient) is a measurement scale for use with the Resonance Frequency Analysis (RFA) method of determining implant stability. The measurement is made using the Osstell Mentor equipment (Osstell, Sweden) with SmartPegs. ISQ values range from 1 to 100, the higher the score the higher the stability. The highest and lowest score obtained from perpendicular measurements will be registered.

    2. ISQ (Implant Stability Quotient) [7 days after surgery]

    3. ISQ (Implant Stability Quotient) [14 days after surgery]

    4. ISQ (Implant Stability Quotient) [21 days after surgery]

    5. ISQ (Implant Stability Quotient) [28 days after surgery]

    6. ISQ (Implant Stability Quotient) [6 weeks after surgery]

    7. ISQ (Implant Stability Quotient) [12 weeks after surgery]

    8. ISQ (Implant Stability Quotient) [6 months after surgery]

    9. ISQ (Implant Stability Quotient) [12 months after surgery]

    10. ISQ (Implant Stability Quotient) [24 months after surgery]

    11. ISQ (Implant Stability Quotient) [36 months after surgery]

    Secondary Outcome Measures

    1. Time of minimum ISQ (Implant stability quotient) [0, 7, 14, 21 and 28 days after surgery]

      Implant stability can be seen as a combination of mechanical stability, which is the result of compressed bone holding the implant tightly in place, and biological stability, which is the result of new bone forming at the site of implantation and osseointegration. Mechanical stability is generally high immediately after implant placement and is decreasing with time. Biological stability, on the other hand, is non-existent immediately after placement and increases with time. The final stability level for an implant is the sum of the two. There is likely to be an initial decrease in stability followed by a subsequent increase as the implant becomes biologically stable. ISQ (implant Stability Quotient) is a measurement scale for use with the Resonance Frequency Analysis (RFA) method of determining implant stability.

    2. ISQ (Implant stability quotient) gradient [0, 7, 14, 21 and 28 days, 6 weeks, 12weeks, 6 months after surgery]

      ISQ (implant stability quotient) per time unit gives a measure of osseointegration speed.

    3. Skin condition according to Holgers score [7 days after surgery]

      Holgers score is a standardized scale to clinically assess skin condition around a percutaneous implant

    4. Skin condition according to Holgers score [14 days after surgery]

    5. Skin condition according to Holgers score [21 days after surgery]

    6. Skin condition according to Holgers score [28 days after surgery]

    7. Skin condition according to Holgers score [6 weeks after surgery]

    8. Skin condition according to Holgers score [12 weeks after surgery]

    9. Skin condition according to Holgers score [6 months after surgery]

    10. Skin condition according to Holgers score [12 months after surgery]

    11. Skin condition according to Holgers score [24 months after surgery]

    12. Skin condition according to Holgers score [36 months after surgery]

    13. Glasgow Benefit Inventory Questionnaire [3 months after surgery]

      Glasgow Benefit Inventory Questionnaire (GBI) 18-item, post-surgical questionnaire given to patients. The GBI measures the change in health status produced by surgical interventions (here, "health status" is the general perception of well-being, including total psychological, social, and physical well being).

    14. Glasgow Benefit Inventory Questionnaire [12 months after surgery]

    15. Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire [Before surgery]

      The APHAB is a 24-item self-assessment inventory in which patients report the amount of trouble they are having with communication or noises in various everyday situations. Benefit is calculated by comparing the patient's reported difficulty in the unaided condition with their amount of difficulty when using amplification. The APHAB produces scores for 4 subscales: Ease of Communication (EC), Reverberation (RV), Background Noise (BN), and Aversiveness (AV).

    16. Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire [6 months after surgery]

    17. Abbreviated Profile of Hearing Aid Benefit (APHAB) questionnaire [36 months after surgery]

    18. Glasgow Health Status Inventory (GHSI) questionnaire [Before surgery]

      The Glasgow Health Status Inventory is an 18 item questionnaire. It assesses health state, by measuring the effect of a health problem on the quality of life of a person. It allows cross-comparison among many health conditions, among different health interventions, and among demographic and cultural subgroups.

    19. Glasgow Health Status Inventory (GHSI) questionnaire [6 months after surgery]

    20. Glasgow Health Status Inventory (GHSI) questionnaire [36 months after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years or older

    • Patient indicated for an ear level bone anchored sound processor

    • Bone thickness at the implant site of at least 4 mm

    Exclusion Criteria:
    • Longer abutment (>6mm) required

    • Inability to participate in follow-up

    • Psychiatric disease in the medical history

    • Mental disability

    • Presumed doubt, for any reason, that the patient will be able to show up on all follow ups

    • Diseases or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Medical Center St Radboud Nijmegen Netherlands 6500

    Sponsors and Collaborators

    • Oticon Medical

    Investigators

    • Principal Investigator: Myrthe KS Hol, MD, PhD, University Medical Center St Radboud, Nijmegen, The Netherlands

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Oticon Medical
    ClinicalTrials.gov Identifier:
    NCT01738490
    Other Study ID Numbers:
    • C33
    First Posted:
    Nov 30, 2012
    Last Update Posted:
    Nov 27, 2017
    Last Verified:
    Nov 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Oticon Medical
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 27, 2017